Details

Evaluation of selected inflammatory markers in cats with feline infectious peritonitis before and after therapy
ID Tršar, Lina (Author), ID Štrljič, Marjeta (Author), ID Nemec Svete, Alenka (Author), ID Koprivec, Saša (Author), ID Tozon, Nataša (Author), ID Krofič, Martina (Author), ID Pavlin, Darja (Author)

.pdfPDF - Presentation file, Download (1,11 MB)
MD5: 30EA0D3EE233545381F3B1816588300A
URLURL - Source URL, Visit https://bmcvetres.biomedcentral.com/articles/10.1186/s12917-025-04731-x This link opens in a new window

Abstract
Background Feline infectious peritonitis (FIP), once considered fatal disease with a mortality rate approaching 100%, has experienced a new therapeutic breakthrough in recent years. The aim of our study was to evaluate selected clin- icopathological parameters before and after GS- 445124-based treatment of FIP in cats, which could serve as potential candidates for predicting treatment success and monitoring treatment progress. Results Pre-treatment haematological parameters in 32 treated cats showed moderate leukocytosis, neutro- philia, lymphopenia and anaemia, which normalised post-treatment. Pre-treatment values of haemogram- derived inflammatory markers (ratio of neutrophils to lymphocytes, platelets to lymphocytes, lymphocytes to monocytes and the systemic immune-inflammatory index) differed significantly from those in the healthy cats and between patients with effusive and non-effusive disease (p < 0.05). Post-treatment, only the ratio of lymphocytes to monocytes remained higher; the other three markers were comparable to the control group. The biochemical results showed characteristic abnormalities (e.g. hyperproteinaemia, hypoalbuminemia, hypergammaglobulinemia, hyperbilirubinemia), which normalised with treatment. Lactate dehydrogenase activities did not differ significantly before and after treatment, except in cats with a relapse and one non-responder, which had markedly elevated values at the time of diagnosis. Analysis of archived blood samples using ELISA revealed significant differences in concen- tration of acute-phase protein haptoglobin (p = 0.004) and pro-inflammatory cytokine tumour necrosis factor-α (p = 0.028) before and after therapy. Therapy didn’t elicit any statistically significant changes in concentrations of ferritin, interleukin- 1β and interleukin- 6. Conclusions Our findings demonstrate that successful treatment of FIP leads to highly significant changes in most clinicopathological parameters, including haemogram-derived inflammatory markers. The latter could offer a sim- ple, inexpensive and readily available alternative to the more commonly used acute phase proteins for monitoring FIP treatment. Successful therapy leads to a significant decrease in haptoglobin and an increase in tumour necrosis factor-α. In our study, cats with an unfavourable outcome showed a marked increase in lactate dehydrogenase activ- ity before therapy, suggesting that this parameter could be a promising prognostic factor in larger studies.

Language:English
Keywords:cats, FIP, inflammatory response, haemogram-derived inflammatory markers, acute phase proteins
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:VF - Veterinary Faculty
Publication status:Published
Publication version:Version of Record
Year:2025
Number of pages:15 str.
Numbering:Vol. 21, art. 330
PID:20.500.12556/RUL-169066 This link opens in a new window
UDC:636.09:616
ISSN on article:1746-6148
DOI:10.1186/s12917-025-04731-x This link opens in a new window
COBISS.SI-ID:235340291 This link opens in a new window
Publication date in RUL:09.05.2025
Views:522
Downloads:108
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:BMC veterinary research
Publisher:BioMed Central.
ISSN:1746-6148
COBISS.SI-ID:515674393 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Projects

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P4-0053
Name:Endokrini, imunski in encimski odzivi pri zdravih in bolnih živalih

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back